Detalhe da pesquisa
1.
Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN).
Circ J
; 87(6): 857-865, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908118
2.
Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial.
Catheter Cardiovasc Interv
; 93(1): E1-E7, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286520
3.
Bioresorbable Scaffold: The Emerging Reality and Future Directions.
Circ Res
; 120(8): 1341-1352, 2017 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408454
4.
Hemodynamic analysis of a novel bioresorbable scaffold in porcine coronary artery model.
Catheter Cardiovasc Interv
; 91(6): 1084-1091, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843033
5.
First-in-Man Trial of SiO2 Inert-Coated Bare Metal Stent System in Native Coronary Stenosisã- The AXETIS FIM Trial.
Circ J
; 82(2): 477-485, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717068
6.
Bioresorbable Vascular Scaffolds for Coronary Revascularization.
Circulation
; 134(2): 168-82, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27400899
7.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
; 388(10059): 2479-2491, 2016 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27806897
8.
Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
Catheter Cardiovasc Interv
; 89(6): 994-1002, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27527508
9.
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
Eur Heart J
; 37(3): 229-40, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26405232
10.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
; 385(9962): 43-54, 2015 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230593
11.
Impact of Implantation Technique and Plaque Morphology on Strut Embedment and Scaffold Expansion of Polylactide Bioresorbable Scaffoldã- Insights From ABSORB Japan Trial.
Circ J
; 80(11): 2317-2326, 2016 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27725525
12.
Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.
Circulation
; 125(19): 2343-53, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508795
13.
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
Lancet
; 380(9852): 1482-90, 2012 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951305
14.
Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease.
Int J Mol Sci
; 14(12): 24492-500, 2013 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24351829
15.
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.
JACC Cardiovasc Interv
; 16(23): 2884-2896, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877914
16.
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.
Lancet
; 378(9807): 1940-8, 2011 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075451
17.
Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold.
Circ J
; 76(2): 342-50, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22104034
18.
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.
Circ J
; 76(7): 1616-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531596
19.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Eur Heart J
; 32(3): 294-304, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21123276
20.
Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.
Eur Heart J
; 32(19): 2454-63, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659439